SCHEMBL7496535

SCHEMBL7496535

O=C(O)C1CCCc2sc(CN3CCN(S(=O)(=O)c4cc5ccc(Cl)cc5s4)CC3=O)nc21

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.55
F2 P00734 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1384904 0.93 F10 (0.58) F10F2
SCHEMBL1385405 0.90 F10 (0.57) F10F2
SCHEMBL1385212 0.90 F10 (0.51) F10F2
SCHEMBL1385011 0.83 F10 (0.62) F10F2
SCHEMBL7149149 0.83 F10 (0.49) F10F2
SCHEMBL1387011 0.82 F10 (0.61) F10F2
SCHEMBL1386989 0.81 F10 (0.58) F10F2
SCHEMBL1386988 0.81 F10 (0.58) F10F2
SCHEMBL1386684 0.79 F10 (0.60) F10F2
SCHEMBL7502167 0.78 F10 (0.55) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed